Patient Preference and Treatment Satisfaction With a Port Delivery System for Ranibizumab vs Intravitreal Injections in Patients With Neovascular Age-Related Macular Degeneration
Sign Up to like & getrecommendations! Published in 2022 at "JAMA Ophthalmology"
DOI: 10.1001/jamaophthalmol.2022.1091
Abstract: Key Points Question Do patients with neovascular age-related macular degeneration (nAMD) treated with a surgically implanted port delivery system (PDS) with ranibizumab prefer the PDS over intravitreal injections of anti–vascular endothelial growth factor agents? Findings… read more here.
Keywords: patients neovascular; treatment satisfaction; intravitreal injections; treatment ... See more keywords
Predictors of good visual outcomes in patients with neovascular age-related macular degeneration in daily practice.
Sign Up to like & getrecommendations! Published in 2020 at "Journal francais d'ophtalmologie"
DOI: 10.1016/j.jfo.2020.02.032
Abstract: PURPOSE To report predictive factors for therapeutic response to anti-VEGF in patients with neovascular age-related macular degeneration (nAMD) in daily clinical practice in our patient population. METHODS Retrospective cohort study including 56 patients (69 eyes)… read more here.
Keywords: anti vegf; patients neovascular; macular degeneration; age related ... See more keywords
The changing landscape for the management of patients with neovascular AMD: brolucizumab in clinical practice
Sign Up to like & getrecommendations! Published in 2022 at "Eye"
DOI: 10.1038/s41433-022-02008-3
Abstract: Untreated neovascular age-related macular degeneration (nAMD) can lead to severe and permanent visual impairment. The chronic nature of the disease can have a significant impact on patients’ quality of life and an economic and time… read more here.
Keywords: neovascular amd; management patients; patients neovascular; amd brolucizumab ... See more keywords
CHORIOCAPILLARIS STRUCTURE IN THE FELLOW EYES OF PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
Sign Up to like & getrecommendations! Published in 2023 at "Retina"
DOI: 10.1097/iae.0000000000003660
Abstract: Supplemental Digital Content is Available in the Text. Multiple averaging en face swept source optical coherence tomography angiography improves visualization of the choriocapillaris, which is suitable for the quantification of its structure. Flow void area… read more here.
Keywords: patients neovascular; choriocapillaris; age related; fellow eyes ... See more keywords
Role of intraretinal and subretinal fluid on clinical and anatomical outcomes in patients with neovascular age-related macular degeneration treated with bimonthly, treat-and-extend and as-needed ranibizumab in the In-Eye study.
Sign Up to like & getrecommendations! Published in 2021 at "Acta ophthalmologica"
DOI: 10.1111/aos.14786
Abstract: PURPOSE To assess the effect of fluid status at baseline (BL) and at the end of the loading phase (LP) of three different ranibizumab regimens: treat-and-extend (T&E), fixed bimonthly (FBM) injections and pro re nata… read more here.
Keywords: patients neovascular; bcva; fluid; study ... See more keywords
Repeated intravitreal injections of antivascular endothelial growth factor in patients with neovascular age-related macular degeneration may increase the risk of ischemic optic neuropathy
Sign Up to like & getrecommendations! Published in 2019 at "BMC Ophthalmology"
DOI: 10.1186/s12886-019-1284-x
Abstract: BackgroundPrevious case reports have demonstrated the occurrence of ischemic optic neuropathy (ION) following intravitreal injections of antivascular endothelial growth factor (anti-VEGF). However, no previous studies have investigated the impact of injection numbers on the risk… read more here.
Keywords: patients neovascular; risk; age; study ... See more keywords
A 12-month, prospective, observational study of ranibizumab in treatment-naïve Taiwanese patients with neovascular age-related macular degeneration: the RACER study
Sign Up to like & getrecommendations! Published in 2020 at "BMC Ophthalmology"
DOI: 10.1186/s12886-020-01715-3
Abstract: Background The current National Health Insurance scheme in Taiwan reimburses 3 initial plus 4 additional injections of ranibizumab 0.5 mg for eligible patients with neovascular age-related macular degeneration (nAMD). The Ranibizumab AMD Clinical Efficacy in Real-world… read more here.
Keywords: patients neovascular; taiwanese patients; treatment; study ... See more keywords
Elevated Levels of Serum IL-17A Secondary to Repeated Intravitreal Injections of Aflibercept in Treatment-Naive Patients with Neovascular Age-Related Macular Degeneration
Sign Up to like & getrecommendations! Published in 2020 at "Applied Sciences"
DOI: 10.3390/app10124109
Abstract: We evaluated the effect of three monthly intravitreal injections of aflibercept on the serum concentration of interleukin 17A (IL-17A), monocyte chemoattractant protein 1 (MCP-1/CCL2), vascular endothelial growth factor (VEGF) and placental growth factor (PlGF) in… read more here.
Keywords: patients neovascular; naive patients; injections aflibercept; intravitreal injections ... See more keywords
Quantitative physiological measurements to evaluate the response of antivascular endothelial growth factor treatment in patients with neovascular diseases
Sign Up to like & getrecommendations! Published in 2017 at "Indian Journal of Ophthalmology"
DOI: 10.4103/ijo.ijo_278_17
Abstract: Antivascular endothelial growth factor (VEGF) treatment is still used intravitreally worldwide for various neovascular diseases, despite other available, approved treatments. We performed a systematic search of the literature focused on visual physiology studies. We used… read more here.
Keywords: patients neovascular; antivascular endothelial; endothelial growth; treatment ... See more keywords